Low-intensity pulsed ultrasound responsive phase-change nanoparticles loaded with rapamycin for targeted therapy of atherosclerotic plaques
Abstract
< 0.001), highlighting the therapeutic efficacy of the nanosystem. This ultrasound-triggered, peptide-targeted strategy integrates imaging and therapy, offering a promising approach for precise AS intervention with significant clinical translational potential.
Fields of Study & Subjects
Ultrasound and Hyperthermia Applications
Nanoplatforms for cancer theranostics
Nanoparticle-Based Drug Delivery
Publication details
- Journal / source
- RSC Advances
- Volume
- 16
- Issue
- 2
- Pages
- 1078–1094
- Publication date
- 1 January 2026
- Language
- EN